Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include Enthera Pharmaceuticals and Viking Therapeutics.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. |  Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders. | |
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Milan, IT HQ Milan, IT Milan, IT | Locations San Diego, US HQ |
Employees | Employees 525% increase | Employees 225% increase | Employees 2729% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 32.8m | Total funding raised $ 15m |
For sources of this data, please see the company profile
View Company Profiles
Enthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View companyViking Therapeutics
HQ
San Diego, US
Employees
27↑ 29% increase
Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.
View company